Another box ticked as we progress the pivotal phase 3 trial. Looking forward to the next major catalyst in a few weeks, the ethics approval. Partnership should hopefully be close as well. Add in the free options and this is really setting up to be an exciting year for PAR investors
Ann: PAR Selects Advanced Clinical as CRO for Phase 3, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $120.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 28.0¢ | $97.62K | 331.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 74197 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 54675 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |